Jade Biosciences JBIO
NASDAQ JBIO
$15.10 +0.24 (+1.62%)
As of: Oct 21, 2026 · 3:59 PM EDT

Jade Biosciences (JBIO) Operating Expenses (2020 - 2026)

Updated

Jade Biosciences (JBIO) reported Operating Expenses of $58.92 million for Q2 2026, up 112.1% from $27.78 million a year earlier and up 35.6% from the prior quarter.

Analysis

Jade Biosciences (JBIO) Operating Expenses (2020 - 2026) Analysis & Trends

Over the twelve months ended Jun 30, 2026, Jade Biosciences' Operating Expenses came in at $164.74 million, up 383.7% year-over-year; for FY2025, it came in at $113.54 million, up 52.2% from FY2024.

  • Operating Expenses has a five-year compound annual growth rate of 66.4% (FY2020 to FY2025).
  • By year, Operating Expenses came in at $74.6 million in FY2024 (-8.4%), $81.41 million in FY2023 (+52.9%), $53.24 million in FY2022 (+131.2%) and $23.02 million in FY2021 (+159.0%).
  • The Q2 2026 figure ranks as the highest quarterly Operating Expenses in data going back to Q2 2020.
  • Year over year, Operating Expenses gained in four of the last six quarters, with growth averaging 41.3%.
  • The high point for year-over-year Operating Expenses in five years was Q1 2022 (growth of 296.4%); the low point was Q3 2024 (a decline of 27.2%).
  • Per Business Quant data, the three quarters before Q2 2026 came in at $43.45 million (Q1 2026), $34.98 million (Q4 2025) and $27.4 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Opex (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn 7.95 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn 10.12 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn 10.56 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn 12.80 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn 6.09 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn 9.70 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn 6.54 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn 18.20 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn 6.68 Bn
10 Jade Biosciences 925.91 Mn -381.71 Mn - 58.92 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 58.92 Mn
Mar 31, 2026 43.45 Mn
Dec 31, 2025 34.98 Mn
Sep 30, 2025 27.40 Mn
Jun 30, 2025 27.78 Mn
Mar 31, 2025 23.38 Mn
Dec 31, 2024 6.40 Mn
Sep 30, 2024 15.56 Mn
Jun 30, 2024 26.17 Mn
Mar 31, 2024 24.62 Mn
Dec 31, 2023 22.07 Mn
Sep 30, 2023 21.37 Mn
Jun 30, 2023 20.34 Mn
Mar 31, 2023 17.64 Mn
Dec 31, 2022 15.85 Mn
Sep 30, 2022 14.15 Mn
Jun 30, 2022 12.22 Mn
Mar 31, 2022 11.02 Mn
Dec 31, 2021 8.27 Mn
Sep 30, 2021 6.20 Mn
API Access

Jade Biosciences Operating Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=operating-expenses&ticker=JBIO&period=max&api_key=YOUR_API_KEY